Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 0.202\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) CCC(=O)Nc1cccc(NC(=O)c2cccc([N+](=O)[O-])c2)c1
b) Cc1cc(NC(=O)c2ccc(Cn3nc(C)c(Br)c3C)o2)no1
Answer: a. CCC(=O)Nc1cccc(NC(=O)c2cccc([N+](=O)[O-])c2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1cccc(NC(=O)c2cccc([N+](=O)[O-])c2)c1
CCC(=O)Nc1cccc(NC(=O)c2cccc([N+](=O)[O-])c2)c1
3-nitro-N-[3-(propanoylamino)phenyl]benzamide